Nicola Squire

Partner
Full contact info

I’m excited to help businesses thrive by finding pragmatic and commercial solutions to their compensation and benefits issues both in the UK and internationally.

Passions

Travel

Reading

Experience

Ambiq Micro Announces Pricing of $96 Million IPO

July 30, 2025

Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $96 million initial public offering (IPO).

Read more

Related contacts

Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Michael Platt
Partner in Charge – Colorado, Colorado
Kelly Bartling
Special Counsel, Colorado
Grady Chang
Associate, Santa Monica
Keith Berets
Partner, Colorado
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Austin Holt
Partner, Santa Monica
Len Jacoby
Partner, New York
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Patrick Loofbourrow
Partner, Singapore
Barbara Mirza
Partner, Santa Monica
Tim Pitrelli
Partner, Singapore
Nicola Squire
Partner, London
Jeffrey J. Tolin
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Alaina DeBona
Special Counsel, Chicago
Andrew Epstein
Special Counsel, Seattle
Brooke Fritz
Special Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Vince Sampson
Special Counsel, Washington, DC
Michael Shen
Special Counsel, Shanghai
Karen Tsai
Special Counsel, Washington, DC
Blake Martell
Of counsel, San Francisco
Mateus Kaba Aboud
Associate, Chicago
Adam Bloom
Associate, Chicago
Alexis Guillermo Buz
Associate, San Diego
Umer Chaudhry
Associate, Washington, DC
Stefan Cohen
Associate, New York
Megan Drill
Associate, San Diego
Ryan Guo
Associate, New York
Sarah Oliai
Associate, Washington, DC
Samuel Paullin
Associate, Chicago
Taryn Wilkins
Associate, Chicago
Katherine Duplay
Paralegal Specialist, Colorado
Alla Kagan
Paralegal Specialist, San Diego
Robin K. Lee
Paralegal Specialist, Colorado
Brian Youn
Paralegal Specialist, Palo Alto
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

EsoBiotec Announces up to $1 Billion Acquisition by AstraZeneca

March 17, 2025

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to $1 billion on a cash- and debt-free basis.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Simon Amies
Partner, London
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Charlie Lightfoot
Partner, London
Alessandra Murata
Partner, Palo Alto
Guadalupe Sampedro
Partner, London
Stella Sarma
Partner, Brussels
Leo Spicer-Phelps
Partner, London
Nicola Squire
Partner, London
Chris Stack
Partner, London
Jeffrey J. Tolin
Partner, New York
David Wilson
Partner, London
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jack Jones
Special Counsel, London
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kafeel Azher
Associate, London
Sarah Buchik
Associate, New York
Mari Dugas
Associate, Washington, DC
Michael Fernando
Associate, London
Athina Gaki
Associate, Brussels
Elaine Huang
Associate, Palo Alto
Mark Jones
Associate, London
Eerik Kukebal
Associate, London
Chris Lynn
Associate, London
Morgan McCormack
Associate, London
Daniel Millard
Associate, London
Lindsey O'Crump
Associate, Washington, DC
Alexandra Paterson
Associate, London
Zhijing Yu
Associate, Singapore
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

UiPath Acquires Peak

March 12, 2025

Cooley advised UiPath (NYSE: PATH), a leading enterprise automation and artificial intelligence (AI) software company, on its acquisition of Peak, an AI-native company based in Manchester, United Kingdom.

Read more

Related contacts

Russell Anderson
Partner, London
Kevin Cooper
Partner, New York
Caroline Hobson
Partner, London
Aaron Pomeroy
Partner, Colorado
Leo Spicer-Phelps
Partner, London
Nicola Squire
Partner, London
Chris Stack
Partner, London
David Wilson
Partner, London
Christine Graham
Special Counsel, London
Rebecca Ross
Special Counsel, Washington, DC
Shehzad Akram
Associate, London
Olivia Anderson
Associate, London
Harry Calkin
Associate, London
Harry Calkin
Associate, London
Cristina DeBiase
Associate, Boston
Rick Jantz
Associate, Santa Monica
Chris Lynn
Associate, London
Daniel Millard
Associate, London
Juan Nascimbene
Associate, London
Mo Swart
Associate, London

Related Practices & Industries

Hummingbird Bioscience Announces Exclusive Worldwide License Agreement With Callio Therapeutics

March 3, 2025

Cooley advised Hummingbird Bioscience, a Singapore-based biotherapeutics company working at the interface of artificial intelligence and human innovation to discover and develop transformative medicines for hard-to-treat diseases, on its exclusive worldwide license agreement with Callio Therapeutics, a newly launched biotech company focused on realizing the promise of multipayload antibody-drug conjugates (ADCs) to improve cancer therapy.

Read more

Related contacts

James Schneider
Partner, Boston
Jeffrey J. Tolin
Partner, New York
Steven Holm
Counsel, Singapore
Michael Fernando
Associate, London
Michael Bergmann
Partner, Washington, DC
Paula Holland
Partner, London
Nicola Squire
Partner, London
Yi Jia Ng
Special Counsel, Singapore
Bethan Chalmers
Associate, London
Amanda Pacheco
Associate, Palo Alto
Alexandra Paterson
Associate, London
Mara Rosario
Associate, Boston
Arda Can Tekin
Associate, New York

Related Practices & Industries

PetLab Co. Announces Majority Stake Sale to BC Partners

February 26, 2025

Cooley advised PetLab Co., a rapidly growing independent pet supplement brand headquartered in London, on its majority stake sale to BC Partners, a top international investment firm.

Read more

Related contacts

Ben Shribman
Partner, London
Kevin Cooper
Partner, New York
Louise Burt
Associate, London
David Wilson
Partner, London
Eerik Kukebal
Associate, London
Aaron Pomeroy
Partner, Colorado
Paula Holland
Partner, London
Harry Calkin
Associate, London
Rick Jantz
Associate, Santa Monica
Jia Xie
Associate, London
Patrick Flanagan
Partner, New York
Paula Fleckenstein
Associate, Reston
David Walsh
Senior Counsel, Reston
Chris Coulter
Partner, London
Megan Browdie
Partner, Washington, DC
Caroline Hobson
Partner, London
Colm Murphy
Partner, London
Gerard O'Shea
Partner, New York
Lauren A. Reichardt
Partner, New York
Guadalupe Sampedro
Partner, London
Stella Sarma
Partner, Brussels
Leo Spicer-Phelps
Partner, London
Nicola Squire
Partner, London
Chris Stack
Partner, London
Henry Stewart
Partner, London
Michael Tollini
Partner, Washington, DC
Karun Ahuja
Special Counsel, Chicago
Sharon Connaughton
Special Counsel, Washington, DC
Christine Graham
Special Counsel, London
Jack Jones
Special Counsel, London
Cristina DeBiase
Associate, Boston
Athina Gaki
Associate, Brussels
Alexandra Leavy
Associate, New York
Daniel Millard
Associate, London
Megan Mojabi (Flynn)
Associate, London
Breanna Qin
Associate, Palo Alto
Alice Wong
Associate, London
Steven A. Zuckerman
Associate, New York
Margie Murphy
Paralegal Specialist, New York
Jake Ironfield
Transactional Quantitative Analyst, New York
Kafeel Azher
Associate, London

Related Practices & Industries

View more

Admissions and credentials

England and Wales

Rankings and accolades

The Legal 500 UK: Employee Share Schemes (2022)

Chambers & Partners UK - Associate to Watch: Employee Share Schemes & Incentives (2022)

Memberships and affiliations

National Employment Lawyers Association

Share Plan Lawyers

She is always available and is keen to get things done. Her knowledge is well in excess of her experience.

Employee Share Schemes & Incentives – Chambers UK 2024